Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries.

Ragonnet R, Trauer JM, Geard N, Scott N, McBryde ES.

BMC Med. 2019 Nov 22;17(1):208. doi: 10.1186/s12916-019-1452-0.

2.

Strategic investment in tuberculosis control in the Republic of Bulgaria.

Doan TN, Varleva T, Zamfirova M, Tyufekchieva M, Keshelava A, Hristov K, Yaneva A, Gadzheva B, Zhang S, Irbe S, Ragonnet R, McBryde ES, Trauer JM.

Epidemiol Infect. 2019 Nov 18;147:e304. doi: 10.1017/S0950268819001857.

3.

Heterogeneous infectiousness in mathematical models of tuberculosis: A systematic review.

Melsew YA, Adekunle AI, Cheng AC, McBryde ES, Ragonnet R, Trauer JM.

Epidemics. 2019 Oct 17:100374. doi: 10.1016/j.epidem.2019.100374. [Epub ahead of print]

4.

Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and meta-analysis.

Karmakar M, Trauer JM, Ascher DB, Denholm JT.

J Infect. 2019 Dec;79(6):572-581. doi: 10.1016/j.jinf.2019.09.016. Epub 2019 Oct 1.

PMID:
31585190
5.

Modelling tuberculosis control priorities: more of the same will not do.

Wejse C, Ragonnet R, McBryde ES, Trauer JM.

Lancet Glob Health. 2019 Oct;7(10):e1319. doi: 10.1016/S2214-109X(19)30286-4. No abstract available.

6.

Estimating long-term tuberculosis reactivation rates in Australian migrants.

Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT.

Clin Infect Dis. 2019 Jun 27. pii: ciz569. doi: 10.1093/cid/ciz569. [Epub ahead of print]

PMID:
31246254
7.

Profiles of tuberculosis disease activation among contacts of patients with tuberculosis.

Melsew YA, Cheng AC, McBryde ES, Denholm JT, Tay E, Ragonnet R, Trauer JM.

Eur Respir J. 2019 Oct 10;54(4). pii: 1900353. doi: 10.1183/13993003.00353-2019. Print 2019 Oct. No abstract available.

PMID:
31164436
8.

TB, you're a long time cured.

Trauer JM.

Eur Respir J. 2019 Mar 18;53(3). pii: 1900104. doi: 10.1183/13993003.00104-2019. Print 2019 Mar. No abstract available.

PMID:
30886025
9.

The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing.

Melsew YA, Gambhir M, Cheng AC, McBryde ES, Denholm JT, Tay EL, Trauer JM.

BMC Infect Dis. 2019 Mar 12;19(1):244. doi: 10.1186/s12879-019-3870-1.

10.

The role of geospatial hotspots in the spatial spread of tuberculosis in rural Ethiopia: a mathematical model.

Shaweno D, Trauer JM, Denholm JT, McBryde ES.

R Soc Open Sci. 2018 Sep 19;5(9):180887. doi: 10.1098/rsos.180887. eCollection 2018 Sep.

11.

The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective.

Zomer E, Liew D, Tonkin A, Trauer JM, Ademi Z.

Int J Cardiol. 2019 Jun 15;285:1-5. doi: 10.1016/j.ijcard.2019.01.037. Epub 2019 Jan 15.

PMID:
30686493
12.

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW.

Clin Infect Dis. 2019 Jun 18;69(1):159-166. doi: 10.1093/cid/ciy938.

13.

Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia.

Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801218. doi: 10.1183/13993003.01218-2018. Print 2018 Dec.

PMID:
30361251
14.

Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.

Shaweno D, Karmakar M, Alene KA, Ragonnet R, Clements AC, Trauer JM, Denholm JT, McBryde ES.

BMC Med. 2018 Oct 18;16(1):193. doi: 10.1186/s12916-018-1178-4.

15.

Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.

Doan TN, Fox GJ, Meehan MT, Scott N, Ragonnet R, Viney K, Trauer JM, McBryde ES.

J Antimicrob Chemother. 2019 Jan 1;74(1):218-227. doi: 10.1093/jac/dky403.

PMID:
30295760
16.

Agent-based models of malaria transmission: a systematic review.

Smith NR, Trauer JM, Gambhir M, Richards JS, Maude RJ, Keith JM, Flegg JA.

Malar J. 2018 Aug 17;17(1):299. doi: 10.1186/s12936-018-2442-y. Review.

17.

Appropriate comparisons of tuberculosis latency structures with empiric data.

Trauer JM, Ragonnet R, McBryde ES.

Lancet Infect Dis. 2018 Jul;18(7):720-721. doi: 10.1016/S1473-3099(18)30339-6. No abstract available.

PMID:
29976525
18.

Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort.

Rafiei N, Williams J, Mulley WR, Trauer JM, Jenkin GA, Rogers BA.

Nephrology (Carlton). 2019 May;24(5):569-574. doi: 10.1111/nep.13386.

PMID:
29660203
19.

Risk factors for infectiousness of patients with tuberculosis: a systematic review and meta-analysis.

Melsew YA, Doan TN, Gambhir M, Cheng AC, McBryde E, Trauer JM.

Epidemiol Infect. 2018 Feb;146(3):345-353. doi: 10.1017/S0950268817003041. Epub 2018 Jan 17. Review.

PMID:
29338805
20.

Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.

Dale K, Tay E, Trauer JM, Trevan P, Denholm J.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1264-1271. doi: 10.5588/ijtld.17.0338.

PMID:
29297447
21.

Coupled, multi-strain epidemic models of mutating pathogens.

Meehan MT, Cocks DG, Trauer JM, McBryde ES.

Math Biosci. 2018 Feb;296:82-92. doi: 10.1016/j.mbs.2017.12.006. Epub 2017 Dec 27.

PMID:
29288702
22.

A novel Bayesian geospatial method for estimating tuberculosis incidence reveals many missed TB cases in Ethiopia.

Shaweno D, Trauer JM, Denholm JT, McBryde ES.

BMC Infect Dis. 2017 Oct 2;17(1):662. doi: 10.1186/s12879-017-2759-0.

23.

Insights into the origin and identity of the discipline of public health.

Trauer JM.

Med J Aust. 2017 Sep 18;207(6):239. No abstract available.

PMID:
28899323
24.

Modular programming for tuberculosis control, the "AuTuMN" platform.

Trauer JM, Ragonnet R, Doan TN, McBryde ES.

BMC Infect Dis. 2017 Aug 7;17(1):546. doi: 10.1186/s12879-017-2648-6.

25.

Optimally capturing latency dynamics in models of tuberculosis transmission.

Ragonnet R, Trauer JM, Scott N, Meehan MT, Denholm JT, McBryde ES.

Epidemics. 2017 Dec;21:39-47. doi: 10.1016/j.epidem.2017.06.002. Epub 2017 Jun 16.

26.

A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis.

Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES.

BMC Infect Dis. 2017 May 30;17(1):374. doi: 10.1186/s12879-017-2478-6.

27.

Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002-2015.

Dale KD, Tay EL, Trauer JM, Trevan PG, Denholm JT.

BMC Infect Dis. 2017 May 3;17(1):324. doi: 10.1186/s12879-017-2421-x.

28.

Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.

Dale KD, Globan M, Tay EL, Trauer JM, Trevan PG, Denholm JT.

Int J Tuberc Lung Dis. 2017 May 1;21(5):550-555. doi: 10.5588/ijtld.16.0651.

PMID:
28399970
29.

The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.

McBryde ES, Meehan MT, Doan TN, Ragonnet R, Marais BJ, Guernier V, Trauer JM.

Int J Infect Dis. 2017 Mar;56:14-20. doi: 10.1016/j.ijid.2017.01.031. Epub 2017 Feb 2. Review.

30.

Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.

Shaweno D, Shaweno T, Trauer JM, Denholm JT, McBryde ES.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):79-85. doi: 10.5588/ijtld.16.0325.

PMID:
28157469
31.

Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.

Ragonnet R, Trauer JM, McBryde ES, Houben RM, Denholm JT, Handel A, Sumner T.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):60-66. doi: 10.5588/ijtld.16.0297.

32.

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES.

BMC Infect Dis. 2017 Jan 6;17(1):36. doi: 10.1186/s12879-016-2171-1.

33.

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Trauer JM, Achar J, Parpieva N, Khamraev A, Denholm JT, Falzon D, Jaramillo E, Mesic A, du Cros P, McBryde ES.

BMC Med. 2016 Nov 18;14(1):187.

34.

Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.

Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A.

Lancet Glob Health. 2016 Nov;4(11):e816-e826. doi: 10.1016/S2214-109X(16)30265-0. Epub 2016 Oct 6.

35.

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.

Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG.

Lancet Glob Health. 2016 Nov;4(11):e806-e815. doi: 10.1016/S2214-109X(16)30199-1. Epub 2016 Oct 6.

36.

Controlled fire use in early humans might have triggered the evolutionary emergence of tuberculosis.

Chisholm RH, Trauer JM, Curnoe D, Tanaka MM.

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9051-6. doi: 10.1073/pnas.1603224113. Epub 2016 Jul 25.

37.

Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.

Trauer JM, Denholm JT, Waseem S, Ragonnet R, McBryde ES.

Am J Epidemiol. 2016 Jun 15;183(12):1138-48. doi: 10.1093/aje/kwv323. Epub 2016 May 19.

PMID:
27199387
38.

Multidrug-resistant tuberculosis in Australia and our region.

Trauer JM, Cheng AC.

Med J Aust. 2016 Apr 18;204(7):251-3. No abstract available.

PMID:
27078589
39.

Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?

Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES, Denholm JT.

Chest. 2016 Feb;149(2):516-525. doi: 10.1016/j.chest.2015.11.017.

PMID:
26867835
40.

Cognitive Behavioral Therapy for Chronic Insomnia.

Trauer JM, Cunnington D.

Ann Intern Med. 2016 Jan 19;164(2):134-5. doi: 10.7326/L15-0484. No abstract available.

PMID:
26784485
41.

Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics.

Ragonnet R, Trauer JM, Denholm JT, Geard NL, Hellard M, McBryde ES.

Sci Rep. 2015 Oct 20;5:15468. doi: 10.1038/srep15468.

42.

Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.

Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D.

Ann Intern Med. 2015 Aug 4;163(3):191-204. doi: 10.7326/M14-2841. Review.

PMID:
26054060
43.

Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.

Trauer JM, Denholm JT, McBryde ES.

J Theor Biol. 2014 Oct 7;358:74-84. doi: 10.1016/j.jtbi.2014.05.023. Epub 2014 May 27.

44.

Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.

Corbett CL, Johnstone M, Trauer JM, Spruyt O.

J Palliat Med. 2013 May;16(5):537-41. doi: 10.1089/jpm.2012.0377.

PMID:
23822210
45.

Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.

Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, Dowse GK, Dwyer DE, Greenberg ME, Huang QS, Khandaker G, Kok J, Laurie KL, Lee VJ, McVernon J, Walter S, Markey PG; Australia, New Zealand and Singapore Pandemic Serosurveillance Study Group.

Emerg Infect Dis. 2013 Jan;19(1):92-101. doi: 10.3201/eid1901.111643.

46.

Imported malaria in the Northern Territory, Australia--428 consecutive cases.

Gray TJ, Trauer JM, Fairley M, Krause VL, Markey PG.

Commun Dis Intell Q Rep. 2012 Mar 31;36(1):107-13.

47.

Ambulatory oximetry fails to predict survival in chronic obstructive pulmonary disease with mild-to-moderate hypoxaemia.

Trauer JM, Gielen CA, Aminazad A, Steinfort CL.

Respirology. 2013 Feb;18(2):377-82. doi: 10.1111/resp.12010.

PMID:
23126259
48.

Feasibility of latent tuberculosis infection diagnosis by interferon-γ release assay remote from testing facilities.

Trauer JM, Hajkowicz KM, Freeman KG, Krause VL.

Commun Dis Intell Q Rep. 2011 Jun;35(2):168-71.

49.

Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.

Trauer JM, Laurie KL, McDonnell J, Kelso A, Markey PG.

Emerg Infect Dis. 2011 Sep;17(9):1615-23. doi: 10.3201/eid1709.101196.

50.

Supplemental Content

Loading ...
Support Center